September 11, 2017 C-Path, CHDI Foundation, and CDISC Announce Public Review Period for Huntington’s Disease Therapeutic Area User Guide September 11, 2017 TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017 – Critical Path Institute (C-Pa
June 13, 2017 C-Path and CDISC Announce Public Review Period for Duchenne Therapeutic Area Standard June 13, 2017 TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017 – The Clinical Data Interchange Standards Consort
May 9, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research May 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTA
May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1,
April 18, 2017 CDISC Announces New Standard for Major Depressive Disorder to Foster Development of New Treatments April 18, 2017 CDISC Announces New Standard for Major Depressive Disorder to Foster Development of New Treatments Austin, T
March 20, 2017 Critical Path Institute Launches Type 1 Diabetes Consortium March 20, 2017 Critical Path Institute Launches Type 1 Diabetes Consortium Tucson, Ariz., March 20, 2017 –Critical Path Institut
November 2, 2016 CDISC, C-Path, and TransCelerate Announce Therapeutic Area Standard for Kidney Transplant November 2, 2016 CDISC, C-Path, and TransCelerate Announce Therapeutic Area Standard for Kidney Transplant TUCSON, A
November 1, 2016 US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract November 1, 2016 US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract TUCSON, A
October 17, 2016 IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers Oct 17, 2016 IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers US FDA and EMA Let
